Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASI: EA-230 in Cardiac Surgery
NCT03145220Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of EA-230 in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
EA-230
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT03145220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03145220.